These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32605528)

  • 1. Insulin resistance and serum levels of adipokines in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Kuo CY; Tsai TY; Huang YC
    Lupus; 2020 Aug; 29(9):1078-1084. PubMed ID: 32605528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adipokine levels in patients with systemic lupus erythematosus.
    De Sanctis JB; Zabaleta M; Bianco NE; Garmendia JV; Rivas L
    Autoimmunity; 2009 May; 42(4):272-4. PubMed ID: 19811274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.
    Chung CP; Long AG; Solus JF; Rho YH; Oeser A; Raggi P; Stein CM
    Lupus; 2009 Aug; 18(9):799-806. PubMed ID: 19578104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa.
    González-López MA; Vilanova I; Ocejo-Viñals G; Arlegui R; Navarro I; Guiral S; Mata C; Pérez-Paredes MG; Portilla V; Corrales A; González-Vela MC; González-Gay MA; Blanco R; Hernández JL
    Arch Dermatol Res; 2020 Oct; 312(8):595-600. PubMed ID: 31786710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.
    Lee YH; Song GG
    Z Rheumatol; 2017 Nov; 76(9):789-797. PubMed ID: 27515182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus.
    Sada KE; Yamasaki Y; Maruyama M; Sugiyama H; Yamamura M; Maeshima Y; Makino H
    J Rheumatol; 2006 Aug; 33(8):1545-52. PubMed ID: 16881111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of leptin, adiponectin and resistin in patients with ankylosing spondylitis: A systematic review and meta-analysis.
    Yang J; Zhang X; Ma Y; Wu M; Hu X; Han R; Yuan Y; Wang M; Chen M; Jiang S; Tong J; Xu S; Xu J; Shuai Z; Zou Y; Pan F
    Int Immunopharmacol; 2017 Nov; 52():310-317. PubMed ID: 28985620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
    Wakiya R; Ueeda K; Shimada H; Nakashima S; Kameda T; Miyatake N; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
    Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fat, insulin resistance, energy expenditure and serum concentrations of leptin, adiponectin and resistin before, during and after pregnancy in healthy Swedish women.
    Eriksson B; Löf M; Olausson H; Forsum E
    Br J Nutr; 2010 Jan; 103(1):50-7. PubMed ID: 19703326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of circulating resistin, leptin, adiponectin and visfatin levels with Behçet disease: a meta-analysis.
    Lee YH; Song GG
    Clin Exp Dermatol; 2018 Jul; 43(5):536-545. PubMed ID: 29356069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant.
    Shin MJ; Lee JH; Jang Y; Park E; Oh J; Chung JH; Chung N
    Metabolism; 2006 Jul; 55(7):918-22. PubMed ID: 16784964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin, resistin and leptin in paediatric chronic renal failure: correlation with auxological and endocrine profiles.
    Maggio MC; Montaperto D; Maringhini S; Corrado C; Gucciardino E; Corsello G
    J Nephrol; 2014 Jun; 27(3):275-9. PubMed ID: 24449263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistin as a potential marker of renal disease in lupus nephritis.
    Hutcheson J; Ye Y; Han J; Arriens C; Saxena R; Li QZ; Mohan C; Wu T
    Clin Exp Immunol; 2015 Mar; 179(3):435-43. PubMed ID: 25345756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.
    Atwa M; Emara A; Balata M; Youssef N; Bayoumy N; Sherif A; Fiala L
    Int J Dermatol; 2014 Oct; 53(10):e410-20. PubMed ID: 24168156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.
    Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
    Rheumatol Int; 2018 Jun; 38(6):1053-1061. PubMed ID: 29302804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors.
    Vadacca M; Margiotta D; Rigon A; Cacciapaglia F; Coppolino G; Amoroso A; Afeltra A
    J Rheumatol; 2009 Feb; 36(2):295-7. PubMed ID: 19132788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients.
    Yoo DE; Lee MJ; Oh HJ; Kim SJ; Shin DH; Yoo TH; Kang SW; Choi KH; Han DS; Han SH
    Endocr J; 2012; 59(8):685-95. PubMed ID: 22673293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
    Durazzo M; Niro G; Premoli A; Morello E; Rizzotto ER; Gambino R; Bo S; Musso G; Cassader M; Pagano G; Floreani A
    J Gastroenterol; 2009; 44(5):476-82. PubMed ID: 19301087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.